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This data article contains complementary ﬁgures and results related
to the research article entitled “butylated hydroxyanisole induces
distinct expression patterns of Nrf2 and detoxiﬁcation enzymes in
the liver and small intestine of C57BL/6 mice” (Luo et al., 2015 [1]),
which deﬁned the basal and butylated hydroxyanisole (BHA)-
induced expression patterns of Phase II enzymes Nqo1, AKR1B8, and
Ho-1 in the liver and small intestine of C57BL/6 mice. Sulforaphane
[1-isothiocyanato-4-(methylsulﬁnyl)butane] (SFN), a naturally
occurring isothiocyanate derived from cruciferous vegetables, is a
highly potent inducer of phase II cytoprotective enzymes. This
dataset reports the histological changes of Nqo1, AKR1B8, and Ho-1
in wild-type (WT) and Nrf2-/- mice induced by SFN. The mice were
given a 25 mg/kg single oral dose of SFN for 24 h and 48 h. Immu-
nohistochemistry revealed that, in the liver from WT mice, SFN
increased Nqo1 staining in hepatocytes with slight higher staining
in the pericentral region. The induction of AKR1B8 appeared mostly
in hepatocytes in the periportal region. The basal and inducible Ho-
1 was located predominately in Kupffer cells. In the small intestinevier Inc. This is an open access article under the CC BY license
/j.taap.2015.08.006
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Fig. 1. Characterization of antibody against Keap
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L. Luo et al. / Data in Brief 5 (2015) 416–423 417from WT mice, the inducible expression of Nqo1 and AKR1B8
appeared more obvious in the villus than that in the crypt.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Biology
ore speciﬁc sub-
ject areaPharmacology, Toxicologyype of data Image, text ﬁle, graph
ow data was
acquiredImages of immunohistochemistry were captured under a light microscope.
Western immunoblot was scanned on an Odyssey scanner.ata format Raw, analyzed
xperimental
factorsC57BL/6 Mice treated with sulforaphane (SFN)xperimental
featuresImmunohistochemistry and western blot were used to analyze the expres-
sion of Nrf2 regulated Phase II enzymes in WT and Nrf2-/- mice.ata source location The School of Medicine, Zhejiang University, Hangzhou, China
ata accessibility The data are supplied with this articleValue of the data
 The data contain information for the generation and characterization of antibodies against Keap1,
NQO1, AKR1B10 and HO-1.
 The data provide a histological view of inducible Nqo1, AKR1B8 and Ho-1 by SFN in vivo.
 The data may provide a better understanding on the chemopreventive effects of SFN.1. Cell extracts (30 μg) from Hek293T cells transfected with the mKeap1
cells (lane 2), and H460 cells (lane 3) were analyzed by Western immu-
ilution). The Keap1 antibody reacted with the endogenous Keap1 and the
Fig. 2. Characterization of antibody against Ho-1. (A) Cell extracts (100 μg) from the small intestine of WT (lane 2) and Nrf2-/-
(lane 3) mice were analyzed by Western immunoblotting with antibody against Ho-1. The Ho-1 antibody showed a decrease of
Ho-1 in the small intestine from Nrf2-/- mice. Lane 1, Puriﬁed His-tagged HO-1. (B) Puriﬁed His-tagged HO-1 (1–100 ng)
analyzed with the Ho-1 antibody. The antibody reacted with 10 ng His-HO-1 (lane 2). The dilution of the antibody was 1:2000.
Fig. 3. Characterization of antibody against NQO1. (A) Cell extracts (100 μg) from the small intestine of Nrf2-/- mice (lane 2) and
WT (lane 3) were analyzed by Western immunoblotting with antibody against NQO-1, which showed a decrease in the small
intestine of Nrf2-/- mice. Lane 1, Puriﬁed His-tagged NQO-1. (B) Puriﬁed His-tagged NQO-1 (1–100 ng) was analyzed with the
NQO-1 antibody. The antibody reacted with 1 ng His-NQO-1. The dilution of the antibody was 1:3000.
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This dataset ﬁrstly shows the sensitivity and speciﬁcity of antibodies against Keap1, NQO1, AKR1B10 and
HO-1. The antibodies were subsequently used for the immunohistochemical analysis on tissues sections
fromWT and Nrf2-/- mice treated by SFN. Figs. 7 and 8 display a similar inducible expression pattern of the
Fig. 4. Characterization of antibody against AKR1B10. (A) Cell extracts (100 μg) from MCF7 cells treated with DMSO (lane 1)
and 20 μM tBHQ (lane 2) were analyzed by Western immunoblotting with antibody against AKR1B10. AKR1B10 antibody
detected the induction of AKR1B10 by tBHQ in MCF7 cells. (B) Puriﬁed His-tagged AKR1B10 (1–100 ng) was analyzed with the
AKR1B10 antibody. The antibody reacted with 10 ng His-AKR1B10. The dilution of the antibody was 1:10000. (C) AKR1B10
reacts strongly with recombinant AKR1B10 and AKR1B8 but not AKR1B3. Full-length N-terminally His-tagged recombinant
AKR1B3 (NM_009658.3), AKR1B8 (NM_008012), and AKR1B10, which had been expressed from a pETDuet-1 plasmid in E. coli
Rosetta cells, were puriﬁed. The recombinant proteins (60 ng) were analysed by immunoblotting with AKR1B10 antibody.
Coomassie stain of His-AKR1B3 (line 1) and His-AKR1B8 (lane 2) (10 μg) are shown in (D).
L. Luo et al. / Data in Brief 5 (2015) 416–423 419detoxiﬁcation enzymes by SFN, in comparison to that by BHA [1]. We evaluated the distribution of Nrf2
and/or its target genes in liver and small intestine in different cell types.2. Experimental design, materials and methods
2.1. Chemicals and reagents
BHA and DL-Sulforaphane (SFN) were from Sigma-Aldrich Co., Ltd. (Shanghai, China). The antibody
Gstα1/2 antiserum was kindly provided by Professor John Hayes (University of Dundee, Scotland).2.2. Characterization of antibody
Antiserum against mouse Keap1 was raised in New Zealand White female rabbits against a pur-
iﬁed full-length N-terminally His-tagged recombinant Keap1 that had been expressed from a pET-15b
plasmid (Clontech, Mountain View, CA) in Escherichia coli Rosetta cells (Novagen, Merck, Darmstadt,
Fig. 5. Immunohistochemical analysis of IgG in the liver (A) and small intestine (B) from BHA-treated mice. Sections of the liver
and small intestine of WT mice given BHA (200 mg/kg) i.g. for 3 days were probed with IgG (1:2000 dilution). (a) Original
magniﬁcation40; (b) Original magniﬁcation100; (c) Original magniﬁcation200.
Fig. 6. BHA increases the expression of Gstα1/2 in the liver and small intestine from WT mice. WT and Nrf2-/- mice were given
BHA (200 mg/kg) or oil (vehicle) by oral gavage for 3 days. Soluble extracts from the liver (A) and small intestine (SI) (B) were
analyzed by Western immunoblotting with antibodies against Gstα1/2. Each lane shows the results for a sample from a single
mouse. Actin was used as a loading control.
L. Luo et al. / Data in Brief 5 (2015) 416–423420Germany). The characterization of Keap1 antibodies were analyzed by Western immunoblotting
(Fig. 1). The Keap1 antibody can react with the endogenous Keap1 and the exogenous GFP-Keap1.
Antisera against HO-1, NQO1, and AKR1B10 were also raised in the rabbits against puriﬁed full-
length N-terminally His-tagged recombinant human HO-1 (NM_002133.2), NQO1 (NM_000903.2),
and AKR1B10 (NM_020299.4), which had been expressed from a pETDuet-1 plasmid (Novagen) in E.
coli Rosetta cells. All antisera were afﬁnity puriﬁed using Protein A resins and kits from Pierce Protein
Biology Products (Thermo Scientiﬁc, USA) before use for Western immunoblotting and immunohis-
tochemistry. The antisera against HO-1 and NQO1 react with mouse Ho-1 and Nqo1, respectively. The
antiserum against AKR1B10 reacts with AKR1B8. The characterization of these antibodies is shown in
Figs. 2–4.
Fig. 7. SFN increased the expression of Nqo1, AKR1B8 and Ho-1 in WT mouse liver. WT and Nrf2-/- mice treated with oil or SFN
(25 mg/kg) by single oral gavage. Mice were sacriﬁced 24 h and 48 h later (n¼3). (A) Crude extracts from the liver were
analyzed by Western immunoblotting with antibodies against Nqo1, Ho-1 or AKR1B8. Each lane shows the results for a sample
from a single mouse. Actin was used as a loading control. Lane 1 and 4 show the results from the mice 48 h after the oil
treatment. Sections of livers from mice 48 h after SFN (b and d) or oil treatment (a and c) were probed with antibodies against
Nqo1 (B), AKR1B8 (C) or Ho-1 (D). (e) Semi-quantitative result of IHC (a–d). (B) and (C), Original magniﬁcation40. (D),
Original magniﬁcation400. Scale bars, 50 μm; The control (oil) was set at 100%. Values are mean7SD. (n¼3; *po0.05,
**po0.01).
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C57BL/6 wild-type (WT) mice were purchased from Shanghai Laboratory Animal Center (CAS,
Shanghai, China). Nrf2-/- mice were kindly provided by Prof. Masayuki Yamamoto (University of
Tsukuba, Japan)[5]. Six–week-old male WT and Nrf2-/- mice were divided into two groups (n¼3), and
given corn oil, or 25 mg/kg SFN orally once to induce Nrf2 regulated Phase II enzymes. Livers and
Fig. 8. SFN increased the expression of Nqo1, AKR1B8 and Ho-1 in WT mouse small intestine. WT and Nrf2-/- mice treated with
oil or SFN (25 mg/kg) by single oral gavage. Mice were sacriﬁced 24 h and 48 h later (n¼3). (A) Crude extracts from the small
intestine were analyzed by Western immunoblotting with antibodies against Nqo1, Ho-1 or AKR1B8. Each lane shows the
results for a sample from a single mouse. Actin was used as a loading control. Lane 1 and 4 show the results from the mice 48 h
after the oil treatment. Sections of small intestine from the mice 48 h after SFN (b and d) or oil treatment (a and c) were probed
with antibodies against Nqo1 (B), AKR1B8 (C) and Ho-1 (D). (e) Semi-quantitative result of IHC (a–d). (B–D), Original
magniﬁcation40. Scale bars, 50 μm; The control (oil) was set at 100%. Values are mean7SD. (n¼3; *po0.05, **po0.01).
L. Luo et al. / Data in Brief 5 (2015) 416–423422small intestines were collected at 24 h or 48 h post SFN administration. Six–week-old male WT and
Nrf2-/- mice were divided into two groups (n¼6), and given corn oil, or BHA (200 mg/Kg BW) by oral
gavage daily for three days. The BHA was dissolved in corn oil. The group receiving oil was used as a
negative control. Mice were sacriﬁced 4 h after the last BHA treatment. All animal procedures were
performed with the approval of the Laboratory Animals Ethics Committee of Zhejiang University.
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For Western blot, liver and small intestine extracts were prepared as previously reported [3,4].
Protein samples were separated on SDS-PAGE gels and immunoblotting was carried out using the
standard protocol. Immunoblotting with antibody against actin was performed to conﬁrm equal
loading for whole-cell extracts.
For immunohistochemistry, the livers and small intestines were ﬁxed in 4% paraformaldehyde and
embedded in parafﬁn [2,6]. For immunohistochemistry, the antibodies against Ho-1, Nqo1, and
AKR1B8 were used. The reacted antibody was visualized using Vector Laboratories ImmPRESS
Detection kit, that employs a second antibody conjugated with horseradish peroxidase and a
diaminobenzidine-based stain. All sections were counterstained with Mayer’s hematoxylin. The semi-
quantitative result of IHC was based on the averaged value from three mice per group. For each
mouse, three separate slides were analyzed. Images were captured under a light microscope
(Olympus BX41, Shanghai, China) at 100magniﬁcation. Image Pro Plus 6.0 (Media Cybernetics, Inc. )
was used to calculate the staining intensity. Five microscopic ﬁelds in tissues at 100magniﬁcation
were randomly selected and the integral optical density (IOD) of Nqo1, AKR1B8, and Ho-1 was cal-
culated, and this was considered as the expression level. The control (oil) was set at 100%. As a
negative control, sections of formalin-ﬁxed liver and small intestine from the WT mice treated with
BHA were probed with IgG, and no positive staining was observed ( Figs. 5–8).
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